Bupropion hcl patient assistance program

Some people had these symptoms when they began taking bupropion, and others developed them after several weeks of treatment, or after stopping bupropion. These symptoms happened more often in people who had a history of mental health problems before taking bupropion than in people without a history of mental health problems. It is important for you to follow-up with your healthcare provider until your symptoms go away.

You should also tell your healthcare provider about any symptoms you had during other times you tried to quit smoking, with or without bupropion. Also, tell your healthcare provider about your other medical conditions, including if you:. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Click here for full Prescribing Information, including Medication Guide and Boxed Warning regarding suicidal thoughts and actions. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www. You may also contact Bausch Health Companies Inc.

Are you 18 years of age or older? Consent is not a condition of purchase of goods or services. Text STOP to opt out. Text HELP for help. For Privacy Policy. For SMS Terms. If you would like to receive a digital copay card, please provide your cell phone number.

Biovail Pharmaceuticals, Inc. Emergent Biosolutions, Inc. Genzyme Charitable Foundation, Inc. Ivax Pharmaceuticals Janssen Biotech, Inc. Leo Pharma Inc. Merrimack Pharmaceuticals, Inc. Mission Pharmacal Co. Niche Pharmaceuticals, Inc. Nitromed, Inc.

Organogenesis Inc. Primus Pharmaceuticals ProStrakan, Inc. Observe patients for the occurrence of neuropsychiatric adverse events. Advise patients and caregivers that the patient should stop taking FORFIVO XL and contact a healthcare provider immediately if agitation, depressed mood, or changes in behavior or thinking that are not typical for the patient are observed, or if the patient develops suicidal ideation or suicidal behavior.

In many postmarketing cases, resolution of symptoms after discontinuation of bupropion was reported. However, the symptoms persisted in some cases; therefore, ongoing monitoring and supportive care should be provided until symptoms resolve. Seizures Bupropion can cause seizure and the risk is dose-related risk. The risk of seizures is also related to patient factors, clinical situations, and concomitant medications that lower the seizure threshold [see Warnings and Precautions in full prescribing information].

Data from a comparative trial of bupropion HCl, nicotine transdermal system NTS , and placebo as an aid to smoking cessation suggest a higher incidence of treatment emergent hypertension in patients treated with the combination of sustained-release bupropion HCl and NTS.

Prior to initiating FORFIVO XL, screen patients for a history of bipolar disorder and the presence of risk factors for bipolar disorder eg, family history of bipolar disorder, suicide, or depression. Psychosis and Other Neuropsychiatric Reactions Depressed patients treated with bupropion have had a variety of neuropsychiatric signs and symptoms, including delusions, hallucinations, psychosis, concentration disturbance, paranoia, and confusion.

Angle-closure Glaucoma The pupillary dilation that occurs following use of many antidepressant drugs including FORFIVO XL may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy. In addition, there have been rare, spontaneous postmarketing reports of erythema multiforme, Stevens Johnson syndrome, and anaphylactic shock associated with bupropion.

There are reports of arthralgia, myalgia, fever with rash, and other symptoms of serum sickness suggestive of delayed hypersensitivity. You are encouraged to report negative side effects of prescription drugs to Almatica at or the FDA at www. Just ONE tablet delivers mg bupropion each day.